Streetbeat News

Products Services

LAD

Wheels, a leading fleet management company in North America, has received a significant minority investment from Marubeni Corporation and Lithia & Driveway. This strategic investment aims to enhance Wheels' product offerings and innovation in the fleet management space. The transaction is expected to close in Q3 2024.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 7:07 am

IBM

Crédit Mutuel Alliance Fédérale is enhancing its AI capabilities through an expanded partnership with IBM, utilizing the IBM watsonx platform to save 1 million hours of administrative work and deploy 35 AI use cases.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 7:03 am

SN

SharkNinja, Inc. (NYSE:SN) has partnered with Al Khayyat Investments (AKI) to distribute its home and kitchen products in the UAE. This collaboration marks SharkNinja's entry into the Middle Eastern market, leveraging AKI's extensive distribution network and industry expertise.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 7:01 am

SNY

VIGL

Vigil Neuroscience (NASDAQ:VIGL) has secured a $40 million strategic investment from Sanofi (NASDAQ:SNY) to bolster its Alzheimer's drug development. The investment will fund Vigil's research and development activities, particularly its TREM2 agonist program.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 6:59 am

AYI

MU

NKE

TNXP

WBA

U.S. stock futures are trading lower this morning. Key stocks to watch include Walgreens Boots Alliance, Micron Technology, NIKE, Tonix Pharmaceuticals, and Acuity Brands. Walgreens and Acuity Brands are set to report earnings, Micron reported strong Q3 results but saw a share price drop, NIKE is expected to release earnings after market close, and Tonix Pharmaceuticals announced a public offering.

Portfolio Pulse from Avi Kapoor

June 27, 2024 | 6:59 am

GMAB

Genmab announced that the U.S. FDA approved EPKINLY for the treatment of adults with relapsed or refractory follicular lymphoma after two or more lines of systemic therapy.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 6:54 am

ABBV

AbbVie announced that the U.S. FDA has approved EPKINLY as the first and only T-cell engaging bispecific antibody administered subcutaneously for the treatment of adults with relapsed or refractory follicular lymphoma.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 6:50 am

NVX

NOVONIX Limited announced it has been granted a patent for its proprietary all-dry, zero-waste cathode synthesis technology in Japan. This development could enhance NOVONIX's competitive edge in the battery materials market.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 6:46 am

GOOG

GOOGL

SFTBF

SFTBY

SoftBank Group Corp. is investing $10-$20 million in Jeff Bezos-backed AI startup Perplexity AI, which aims to compete with Google's search engine. This investment is part of a larger $250 million funding round, tripling Perplexity's valuation to $3 billion. The move highlights SoftBank's renewed focus on AI after missing out on Nvidia's rally.

Portfolio Pulse from Benzinga Neuro

June 27, 2024 | 6:42 am

TSLA

Former Tesla executive Martin Viecha praised the Model 3 Performance for its speed and affordability, comparing it to a Porsche. Despite considering other EV brands, Viecha chose Tesla for its Full Self-Driving (FSD) capabilities. The Model 3 Performance starts at $54,990, accelerates from 0 to 60 mph in under 3 seconds, and is eligible for a $7,500 federal EV tax credit.

Portfolio Pulse from Anan Ashraf

June 27, 2024 | 6:09 am